Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma

Kavanagh, JE; Hearn, AP; Dhariwal, J; d'Ancona, G; Douiri, A; Roxas, C; Fernandes, M; Green, L; Thomson, L; Nanzer, AM; Kent, BD; Jackson, DJ

Jackson, DJ (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, Asthma UK Ctr, Guys Severe Asthma Ctr,Guys Hosp,Guys & St Thomas, London SE1 9RT, England.

CHEST, 2021; 159 (2): 496

Abstract

BACKGROUND: Benralizumab is an IL5-receptor monoclonal antibody licensed for the treatment of severe eosinophilic asthma (SEA). It has demonstrated ef......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索